The Rapid Adoption Of Renal Biomarkers To Improve Kidney Disease Diagnosis And Management Is Driven By Healthcare Cost Cutting
The global renal biomarkers market is estimated to be valued at US$ 1700.59 Mn in 2024 and is expected to exhibit a CAGR of 3.7% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.